相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer
Charles G. Drake et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2022)
Human gut bacteria produce TH17-modulating bile acid metabolites
Donggi Paik et al.
NATURE (2022)
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
John A. McCulloch et al.
NATURE MEDICINE (2022)
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazli Dizman et al.
NATURE MEDICINE (2022)
Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer
M. Karayama et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics
Kentaro Inamura
SEMINARS IN CANCER BIOLOGY (2021)
Clinical observation of the efficacy of PD-1/PD-L1 inhibitors in the treatment of patients with advanced solid tumors
Miao Wang et al.
IMMUNITY INFLAMMATION AND DISEASE (2021)
Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Gut microbial metabolites as multi-kingdom intermediates
Kimberly A. Krautkramer et al.
NATURE REVIEWS MICROBIOLOGY (2021)
The gut microbiota-brain axis in behaviour and brain disorders
Livia H. Morais et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Lakshmi Nayak et al.
CLINICAL CANCER RESEARCH (2021)
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Khiem C. Lam et al.
CELL (2021)
Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease
Daniel Erny et al.
CELL METABOLISM (2021)
Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
Vyara Matson et al.
GASTROENTEROLOGY (2021)
Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study
Karuna E. W. Vendrik et al.
LANCET INFECTIOUS DISEASES (2021)
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
Yuying Liu et al.
NATURE IMMUNOLOGY (2021)
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch et al.
SCIENCE (2021)
Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer
Abigail E. Overacre-Delgoffe et al.
IMMUNITY (2021)
Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model
J. N. Rashida Gnanaprakasam et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2021)
Metabolic modulation of tumours with engineered bacteria for immunotherapy
Fernando P. Canale et al.
NATURE (2021)
Microbiota shape tumor immunity
Zoltan Fehervari
NATURE IMMUNOLOGY (2021)
Leveraging diet to engineer the gut microbiome
Mathis Wolter et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Diwakar Davar et al.
SCIENCE (2021)
Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection
Eric R. Littmann et al.
NATURE COMMUNICATIONS (2021)
Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
Yao He et al.
CELL METABOLISM (2021)
Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology
Keman Cheng et al.
NATURE COMMUNICATIONS (2021)
Bacterial Outer Membrane Vesicles: From Discovery to Applications
Mariana G. Sartorio et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 75, 2021 (2021)
Microbiota-derived acetate activates intestinal innate immunity via the Tip60 histone acetyltransferase complex
Bat-Erdene Jugder et al.
IMMUNITY (2021)
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Miles C. Andrews et al.
NATURE MEDICINE (2021)
Host specificity of the gut microbiome
Elizabeth K. Mallott et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Paul Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
How microbiota improve immunotherapy
Eduard Ansaldo et al.
SCIENCE (2021)
Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
Matthew E. Griffin et al.
SCIENCE (2021)
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Maik Luu et al.
NATURE COMMUNICATIONS (2021)
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma
Antoni Ribas et al.
CANCER DISCOVERY (2021)
Enhancing Checkpoint Inhibitor Therapy in Solid Tissue Cancers: The Role of Diet, the Microbiome & Microbiome-Derived Metabolites
Agnieszka Beata Malczewski et al.
FRONTIERS IN IMMUNOLOGY (2021)
High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity
Zaigham Abbas Rizvi et al.
SCIENCE ADVANCES (2021)
Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer
Nadina Tinsley et al.
ONCOLOGIST (2020)
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort
Abdul Rafeh Naqash et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies
Brooke E. Wilson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium
Yanxia Guo et al.
CANCER LETTERS (2020)
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
Yaoyao Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth
Elena Zagato et al.
NATURE MICROBIOLOGY (2020)
Microbiota-Induced Type I Interferons Instruct a Poised Basal State of Dendritic Cells
Laura Schaupp et al.
CELL (2020)
Immune checkpoint signaling and cancer immunotherapy
Xing He et al.
CELL RESEARCH (2020)
Interaction between microbiota and immunity in health and disease
Danping Zheng et al.
CELL RESEARCH (2020)
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa et al.
EUROPEAN UROLOGY (2020)
Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming of Region-Specific Immunity
Thomas M. Fenton et al.
IMMUNITY (2020)
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Daniel S. Leventhal et al.
NATURE COMMUNICATIONS (2020)
Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients
Peng Song et al.
THORACIC CANCER (2020)
Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway
Xinjian Xu et al.
FRONTIERS IN MICROBIOLOGY (2020)
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non -randomised, open -label, phase 2 trial
Sarah B. Goldberg et al.
LANCET ONCOLOGY (2020)
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
Clarissa Campbell et al.
NATURE (2020)
NK cells mediate clearance of CD8(+) T cell-resistant tumors in response to STING agonists
Christopher J. Nicolai et al.
SCIENCE IMMUNOLOGY (2020)
Oral delivery of a single microbial strain, EDP1503, induces anti-tumor responses via gut-mediated activation of both innate and adaptive immunity
D. McHale et al.
ANNALS OF ONCOLOGY (2020)
Commensal bacteria stimulate antitumor responses via T cell cross-reactivity
Catherine A. Bessell et al.
JCI INSIGHT (2020)
Bacterial outer membrane vesicles as a platform for biomedical applications: An update
Min Li et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors
Motoo Nomura et al.
JAMA NETWORK OPEN (2020)
Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy
Shuang Qing et al.
ADVANCED MATERIALS (2020)
A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice
Emma Allen-Vercoe et al.
CANCER CELL (2020)
The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skin
Jeremy Di Domizio et al.
NATURE IMMUNOLOGY (2020)
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager et al.
SCIENCE (2020)
Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling
Xinhua Chen et al.
GASTROENTEROLOGY (2020)
Gut microorganisms act together to exacerbate inflammation in spinal cords
Eiji Miyauchi et al.
NATURE (2020)
Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade
Shan Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer
Taiki Hakozaki et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity
Lydia Kalafati et al.
CELL (2020)
Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction
Tingting Wang et al.
NATURE METABOLISM (2020)
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma
Aly-Khan A. Lalani et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy
Romain Daillere et al.
ONCOIMMUNOLOGY (2020)
Dihydromyricetin attenuates Escherichia coli lipopolysaccharide-induced ileum injury in chickens by inhibiting NLRP3 inflammasome and TLR4/NF-κB signalling pathway
Yicong Chang et al.
VETERINARY RESEARCH (2020)
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
Aurelie Fluckiger et al.
SCIENCE (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Modulating the microbiome to improve therapeutic response in cancer
Jennifer L. McQuade et al.
LANCET ONCOLOGY (2019)
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Takeshi Tanoue et al.
NATURE (2019)
The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant
Delphine L. Laute-Caly et al.
SCIENTIFIC REPORTS (2019)
Nonspecific effects of oral vaccination with live-attenuated Salmonella Typhi strain Ty21a
S. H. Pennington et al.
SCIENCE ADVANCES (2019)
Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy
Kang Liang et al.
CANCER LETTERS (2019)
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
Yueping Jin et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
Sha Zhao et al.
LUNG CANCER (2019)
Roseburia intestinalis inhibits oncostatin M and maintains tight junction integrity in a murine model of acute experimental colitis
Bei Tan et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program
Elena Verzoni et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
Stefanie K. Wculek et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
A Metabolism Toolbox for CAR T Therapy
Xuequn Xu et al.
FRONTIERS IN ONCOLOGY (2019)
Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8+ T Cells
Annabel Bachem et al.
IMMUNITY (2019)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with updates hepatocellular carcinoma
Yi Zheng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immuno-oncology drug development goes global
Jia Xin Yu et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
David J. Pinato et al.
JAMA ONCOLOGY (2019)
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Zachariah DeFilipp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Metabolomic adaptations and correlates of survival to immune checkpoint blockade
Haoxin Li et al.
NATURE COMMUNICATIONS (2019)
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
Kathrin Renner et al.
CELL REPORTS (2019)
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (vol 28, pg 1368, 2017)
N. Chaput et al.
ANNALS OF ONCOLOGY (2019)
Mining the microbiota for microbial and metabolite-based immunotherapies
Ashwin N. Skelly et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Molecular Mechanisms and Countermeasures of Immunotherapy Resistance in Malignant Tumor
Xiaoyue Jiang et al.
JOURNAL OF CANCER (2019)
Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade
Feng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
Barbara Maciejewska et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Guanine and inosine nucleotides/nucleosides suppress murine T cell activation
Yuria Shinohara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors
Matteo Santoni et al.
EUROPEAN UROLOGY (2018)
Dietary Fiber Confers Protection against Flu by Shaping Ly6c- Patrolling Monocyte Hematopoiesis and CD8+ T Cell Metabolism
Aurelien Trompette et al.
IMMUNITY (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells
Chi Ma et al.
SCIENCE (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer
Friedrich H. Schmitz-Winnenthal et al.
ONCOIMMUNOLOGY (2018)
Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy
Yanhai Feng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate
Maik Luu et al.
SCIENTIFIC REPORTS (2018)
STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers
Dayson Moreira et al.
CLINICAL CANCER RESEARCH (2018)
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang et al.
NATURE MEDICINE (2018)
Nod-Like Receptor Pyrin-Containing Protein 6 (NLRP6) Is Up-regulated in Ileal Crohn's Disease and Differentially Expressed in Goblet Cells
Nicole Ranson et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)
Tumour-targeting bacteria engineered to fight cancer
Shibin Zhou et al.
NATURE REVIEWS CANCER (2018)
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12
Mireia Uribe-Herranz et al.
JCI INSIGHT (2018)
Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors
Baokun He et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Neutrophil extracellular traps: protagonists of cancer progression?
L. Erpenbeck et al.
ONCOGENE (2017)
Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer
Sonia Domingos-Pereira et al.
ONCOIMMUNOLOGY (2017)
Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8+ T cell response and better prognosis in HBV-related hepatocellular carcinoma
Yihui Rong et al.
EXPERIMENTAL CELL RESEARCH (2017)
Lactobacillus plantarum Enhanced IL-22 Production in Natural Killer (NK) Cells That Protect the Integrity of Intestinal Epithelial Cell Barrier Damaged by Enterotoxigenic Escherichia coli
Yueqin Qiu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
Bacterial outer membrane vesicles suppress tumor by interferon-γ- mediated antitumor response
Oh Youn Kim et al.
NATURE COMMUNICATIONS (2017)
The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells
Michal P. Kuczma et al.
ONCOTARGET (2017)
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
Arthur E. Frankel et al.
NEOPLASIA (2017)
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis
Yong Huang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
N. Chaput et al.
ANNALS OF ONCOLOGY (2017)
Nucleic acid-sensing TLRs and autoimmunity: novel insights from structural and cell biology
Karin Pelka et al.
IMMUNOLOGICAL REVIEWS (2016)
Microbiome and Anticancer Immunosurveillance
Laurence Zitvogel et al.
CELL (2016)
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Roger Geiger et al.
CELL (2016)
Gut Microbial Metabolites Fuel Host Antibody Responses
Myunghoo Kim et al.
CELL HOST & MICROBE (2016)
Memory CD8+ T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal Function
Maria L. Balmer et al.
IMMUNITY (2016)
Natural Product Anacardic Acid from Cashew Nut Shells Stimulates Neutrophil Extracellular Trap Production and Bactericidal Activity
Andrew Hollands et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Design, Synthesis, and Biological Evaluation of Novel Cyclic Adenosine-Inosine Monophosphate (cAIMP) Analogs That Activate Stimulator of Interferon Genes (STING)
Thierry Lioux et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Randomized Clinical Trial: Impact of Oral Administration of Saccharomyces boulardii on Gene Expression of Intestinal Cytokines in Patients Undergoing Colon Resection
Marcella Lobato D. Consoli et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2016)
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
Krista Dubin et al.
NATURE COMMUNICATIONS (2016)
A novel strain of Bacteroides fragilis enhances phagocytosis and polarises M1 macrophages
Huimin Deng et al.
SCIENTIFIC REPORTS (2016)
An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells
Olga Novikov et al.
MOLECULAR PHARMACOLOGY (2016)
The anacardic 6-pentadecyl salicylic acid induces macrophage activation via the phosphorylation of ERK1/2, JNK, P38 kinases and NF-κB
J. N. Rashida Gnanaprakasam et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Exopolysaccharides Produced by Leuconostoc mesenteroides Strain NTM048 as an Immunostimulant To Enhance the Mucosal Barrier and Influence the Systemic Immune Response
Chiaki Matsuzaki et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)
Cancer's Fuel Choice: New Flavors for a Picky Eater
Gina M. DeNicola et al.
MOLECULAR CELL (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
Colin Hill et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud et al.
SCIENCE (2013)
Emerging Roles of Anacardic Acid and Its Derivatives: A Pharmacological Overview
Mahadevappa Hemshekhar et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2012)
Outer Membrane Vesicles of a Human Commensal Mediate Immune Regulation and Disease Protection
Yue Shen et al.
CELL HOST & MICROBE (2012)
The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon
Dallas R. Donohoe et al.
CELL METABOLISM (2011)
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
Thomas B. Clarke et al.
NATURE MEDICINE (2010)
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling
Chrystal M. Paulos et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system
SK Mazmanian et al.
CELL (2005)